Name
apalyRx
Description
Every Prescription Should Compete: ApalyRx Finds the Lowest Net Cost for Each Script
Self-funded employers carry fiduciary responsibility for every pharmacy dollar, yet most cannot tell whether a given prescription was filled at the best available price. Many PBMs own the mail order and specialty pharmacies their networks steer members toward. Even with a good PBM, no one checks each script against the rest of the market.
ApalyRx is a technology platform that does. Every prescription is assessed in real time against the plan’s current PBM price, contracted retail and independent pharmacies, mail order suppliers, and manufacturer-direct programs. The member is offered the lowest net cost option, and every decision is recorded, including those the PBM wins, giving the plan sponsor a defensible fiduciary record.
When actual claims from multiple employers are repriced at ApalyRx net prices, ApalyRx beats the current PBM price on 85% of scripts and reduces total pharmacy spend by an average of 25%.
ApalyRx owns no pharmacy, takes no spread, and has no stake in where a prescription is filled. More than 8,000 NDCs are available today, with no PBM replacement and no drug-by-drug carve-outs. Claims run through the plan’s TPA or carrier, employers go live in 90 days, and ApalyRx charges only when it delivers savings.
Other innovations help decide who should take a drug. ApalyRx makes sure the plan never pays more than it has to for whatever is prescribed, whether that is a GLP-1 or any other drug on the claims file.
Self-funded employers carry fiduciary responsibility for every pharmacy dollar, yet most cannot tell whether a given prescription was filled at the best available price. Many PBMs own the mail order and specialty pharmacies their networks steer members toward. Even with a good PBM, no one checks each script against the rest of the market.
ApalyRx is a technology platform that does. Every prescription is assessed in real time against the plan’s current PBM price, contracted retail and independent pharmacies, mail order suppliers, and manufacturer-direct programs. The member is offered the lowest net cost option, and every decision is recorded, including those the PBM wins, giving the plan sponsor a defensible fiduciary record.
When actual claims from multiple employers are repriced at ApalyRx net prices, ApalyRx beats the current PBM price on 85% of scripts and reduces total pharmacy spend by an average of 25%.
ApalyRx owns no pharmacy, takes no spread, and has no stake in where a prescription is filled. More than 8,000 NDCs are available today, with no PBM replacement and no drug-by-drug carve-outs. Claims run through the plan’s TPA or carrier, employers go live in 90 days, and ApalyRx charges only when it delivers savings.
Other innovations help decide who should take a drug. ApalyRx makes sure the plan never pays more than it has to for whatever is prescribed, whether that is a GLP-1 or any other drug on the claims file.
Website
